Skip to Content
Merck
  • Human O-sulfated metabolites of (-)-epicatechin and methyl-(-)-epicatechin are poor substrates for commercial aryl-sulfatases: implications for studies concerned with quantifying epicatechin bioavailability.

Human O-sulfated metabolites of (-)-epicatechin and methyl-(-)-epicatechin are poor substrates for commercial aryl-sulfatases: implications for studies concerned with quantifying epicatechin bioavailability.

Pharmacological research (2012-03-01)
S Saha, W Hollands, P W Needs, L M Ostertag, B de Roos, G G Duthie, P A Kroon
ABSTRACT

Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC-MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC-MS/MS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sulfatase from Aerobacter aerogenes, Type VI, buffered aqueous glycerol solution, 2-5 units/mg protein (biuret), 10-20 units/mL
Sigma-Aldrich
Sulfatase from Patella vulgata (keyhole limpet), Type V, essentially salt-free, lyophilized powder, ≥5 units/mg solid
Sigma-Aldrich
Sulfatase from Helix pomatia, Type H-2, aqueous solution, ≥2,000 units/mL
Sigma-Aldrich
Sulfatase from Patella vulgata (keyhole limpet), Type IV, essentially salt-free, lyophilized powder, ≥10 units/mg solid
Sigma-Aldrich
Sulfatase from Helix pomatia, Type H-1, sulfatase ≥10,000 units/g solid
Sigma-Aldrich
Sulfatase from abalone entrails, Type VIII, lyophilized powder, 20-40 units/mg solid